Inventor · disambiguated record
Catherine Bollard
Also filed as: BOLLARD CATHERINE · BOLLARD CATHERINE M · BOLLARD CATHERINE MARY
8 granted patents·15 pending applications·17 citations·filing 2015–2023
78Inventor score
Top patents by PatentIndex Score
23 records- 0192US9885021B2Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic useCHILDRENS NAT MEDICAL CT·Filed 2015·Granted Feb 6, 2018·14 cites·24 claims
- 0285US11999967B2Generating HPV antigen-specific cells from a naive T cell populationCHILDRENS NAT MEDICAL CT·Filed 2021·Granted Jun 4, 2024·1 cites·26 claims
- 0383US10934525B2Generating HPV antigen-specific cells from a naive T cell populationCHILDRENS NAT MEDICAL CT·Filed 2016·Granted Mar 2, 2021·2 cites·25 claims
- 0466US11649437B2Generating HPV antigen-specific cells from a naive T cell populationCHILDRENS NAT MEDICAL CT·Filed 2021·Granted May 16, 2023·0 cites·26 claims
- 0560US2021277355A1Generating virus or other antigen-specific t cells from a naïve t cell populationCHILDRENS NAT MEDICAL CT·Filed 2021·Application pending·0 cites
- 0656US2022160767A1Cytokine cocktails for selective expansion of t cell subsetsCHILDRENS NAT MEDICAL CT·Filed 2021·Application pending·0 cites
- 0755US2024000936A1Kshv oncoprotein antigens and epitopes for expanding antigen-specific t cellsCHILDRENS NAT MEDICAL CT·Filed 2023·Application pending·0 cites
- 0854US12478670B2Generating HPV antigen-specific T cells from a naïve T cell populationCHILDRENS NAT MEDICAL CT·Filed 2021·Granted Nov 25, 2025·0 cites·27 claims
- 0952US2023036213A1T-cell epitopes of human parainfluenza virus 3 for adoptive t-cell immunotherapyCHILDRENS NAT MEDICAL CT·Filed 2020·Application pending·0 cites
- 1052US2024216507A1Sars-cov-2-specific t cells and methods of treatment using themCHILDRENS NAT MEDICAL CT·Filed 2021·Application pending·0 cites
- 1151US2023190902A1Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prameCHILDRENS NAT MEDICAL CT·Filed 2021·Application pending·0 cites
- 1249US2022409716A1T-cell compositions and methods of making and using the sameCHILDRENS NAT MEDICAL CT·Filed 2020·Application pending·0 cites
- 1348US2021046119A1Fixed ratio ex vivo activated mixed lymphocyte products for use in the treatment of cancerCHILDRENS NAT MEDICAL CT·Filed 2019·Application pending·0 cites
- 1447US12168046B2Mycobacterial antigen compositions and methods of useCHILDRENS NAT MEDICAL CT·Filed 2019·Granted Dec 17, 2024·0 cites·3 claims
- 1547US2021213066A1Improved cell therapy compositions for hematopoietic stem cell transplant patientsCHILDRENS NAT MEDICAL CT·Filed 2019·Application pending·0 cites
- 1645US2021371852A1System of cell expansion and methods of using the sameCHILDRENS NAT MEDICAL CT·Filed 2019·Application pending·0 cites
- 1744US2023002730A1Improved targeted t-cell therapyCHILDRENS NAT MEDICAL CT·Filed 2019·Application pending·0 cites
- 1843US2022048988A1Cells expressing antibodies targeting human immunodeficiency virus and methods of using the sameCHILDRENS NAT MEDICAL CT·Filed 2019·Application pending·0 cites
- 1943US2022064598A1Ex vivo activated t-lymphocytic compositions and methods of using the sameCHILDRENS NAT MEDICAL CT·Filed 2020·Application pending·0 cites
- 2041US12227590B2Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 contextTSCHIERSCH PFRELINDSCHUH ASTRID·Filed 2021·Granted Feb 18, 2025·0 cites·7 claims
- 2141US11931465B2Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereofCHILDRENS NAT MEDICAL CT·Filed 2017·Granted Mar 19, 2024·0 cites·15 claims
- 2240US2018072990A1Generating virus or other antigen-specific t cells from a naïve t cell populationCHILDRENS NAT MEDICAL CT·Filed 2016·Application pending·0 cites
- 2340US2023210897A1Modified natural killer cells and methods of using the sameCHILDREN’S NAT MEDICAL CENTER·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catherine Bollard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →